In LPS-induced neuroinflammation models, ALC confers neuroprotection by suppressing the TLR4/NFB pathway, restoring autophagy activity, and inhibiting oxidative stress.[13] ALC reduces microglial activation and release of inflammatory mediators by balancing pro-inflammatory and anti-inflammatory cytokines.[14][15] ALC attenuates microglial activation in a dose-dependent manner, with 100 mg/kg/day showing beneficial effects on LPS-induced neuroinflammation in mice, associated with increased brain-derived neurotrophic factor (BDNF) concentration.[14] In repetitive mild traumatic brain injury models, ALC treatment showed protective effects against neurodegeneration and inflammation, reducing mRNA levels of MAPT, TNF, and GFAP in the cortex.[16] Combination Strategies for Neuroinflammation: ALC 1,500-2,000 mg/day + PEA 1,200 mg/day (complementary anti-inflammatory mechanisms) + Omega-3 fatty acids 2-4 g/day (specialized pro-resolving mediator precursors) + Curcumin 500-1,000 mg/day (complementary NF-B modulation) 4

Point32Health Chief Financial Officer Mike Marrone said the new coverage limits on GLP-1 drugs alone could contribute as much as $100 million or more in savings in 2026
Neuroscience 20 May 2026 Dihexa for CTE (Chronic Traumatic Encephalopathy): The 2026 UK Review Rigorous 2026 UK review of Dihexa for chronic traumatic encephalopathy (CTE)
The dosage of glutathione administered can vary based on individual needs and health conditions
The "Leaky Gut" and IBS Narrative A massive portion of the online search volume for BPC 157 revolves around fixing "leaky gut syndrome" or calming irritable bowel syndrome (IBS)